Gland Pharma Limited Stock price

Equities

GLAND

INE068V01023

Pharmaceuticals

Delayed NSE India S.E. 10:59:01 2024-03-04 pm EST 5-day change 1st Jan Change
1,733 INR +1.48% Intraday chart for Gland Pharma Limited -4.52% -9.61%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 56.59B 683M Sales 2025 * 63.32B 764M Capitalization 281B 3.39B
Net income 2024 * 8.67B 105M Net income 2025 * 11.06B 133M EV / Sales 2024 * 4.49 x
Net cash position 2024 * 27.46B 331M Net cash position 2025 * 31.74B 383M EV / Sales 2025 * 3.94 x
P/E ratio 2024 *
32.5 x
P/E ratio 2025 *
25.4 x
Employees 4,585
Yield 2024 *
0.1%
Yield 2025 *
0.2%
Free-Float 37.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.45%
1 week-6.70%
Current month-3.28%
1 month-14.54%
3 months-5.53%
6 months-0.06%
Current year-11.25%
More quotes
1 week
1 666.80
Extreme 1666.8
1 841.25
1 month
1 666.80
Extreme 1666.8
2 194.00
Current year
1 666.80
Extreme 1666.8
2 194.00
1 year
861.00
Extreme 861
2 194.00
3 years
861.00
Extreme 861
4 350.00
5 years
861.00
Extreme 861
4 350.00
10 years
861.00
Extreme 861
4 350.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 99-12-31
Director of Finance/CFO - 19-09-29
Chief Tech/Sci/R&D Officer - 97-12-31
Members of the board TitleAgeSince
Director/Board Member 54 22-03-09
Chief Executive Officer 54 99-12-31
Chairman 69 19-06-09
More insiders
Date Price Change Volume
24-03-04 1,733 +1.48% 45 638
24-03-04 1,708 -4.84% 528,410
24-03-02 1,795 +0.41% 8,204
24-03-01 1,788 +1.22% 318,279
24-02-29 1,766 -1.99% 244,498

Delayed Quote NSE India S.E., March 04, 2024 at 06:43 am EST

More quotes
Gland Pharma Limited is an India-based generic injectable-focused company. The Company specializes in complex injectables and is engaged in the sterile injectables, oncology, and ophthalmology segments. The Company provides contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a variety of delivery systems. Its products are available in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its products are sold across various countries, which include United States, Europe, Canada, and others.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
1,708 INR
Average target price
1,876 INR
Spread / Average Target
+9.84%
Consensus
  1. Stock
  2. Equities
  3. Stock Gland Pharma Limited - NSE India S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW